Autopsy results from 44 people who died with COVID-19 show how the virus spreads through not just the respiratory system, but the entire body, including the brain, persisting for months in some patients.
A description of the results, published in the peer-reviewed journal Nature in December, highlights how far-reaching the burden of infection can be, with viral fragments found in 79 of 85 locations in the body across the 44 patients.
The small study forms “the most comprehensive analysis to date of the cellular tropism, quantification and persistence of SARS-CoV-2 across the human body, including the brain,” according to its authors.
The virus was able to spread to multiple organs and systems even in patients who died within a week of feeling their first symptoms, researchers found.
The 44 people whose autopsies contributed to this research were all unvaccinated individuals who had died with COVID-19. The median age of the individuals was 62.5 years, and 61.4 per cent had three or more comorbidities. The median span of time between the onset of symptoms and the patient being hospitalized was six days, with 18.5 days being the median interval between symptom onset and death.
Across the board, the autopsies showed that the virus was able to penetrate into numerous systems of the body, although researchers noted there was a significantly higher burden of SARS-CoV-2 RNA found in respiratory tissues. Researchers found the virus had invaded more than 35 cell types and membranes across different systems in the body.
Out of the 44 autopsies, 11 were whole-body and brain autopsies, providing the fullest picture of the viral spread in those individuals.
Of these 11, the two with the shortest duration between symptom onset and death—four days and five days—had the highest amount of viral RNA levels in their respiratory system, with high levels also found across the cardiovascular system and optic tissue, among others.
SARS-CoV-2 was found in at least one place in the central nervous system or brain tissue in 10 out of 11 of these autopsies, including five out of six of those who died more than a month after the first onset of symptoms.
Researchers noted that although there were significant viral traces found, the actual structural tissue of the brain was largely unchanged by the virus.
The individual who had the longest duration between symptom onset and death—230 days—had been hospitalized numerous times and ultimately died of lung transplant complications, not COVID-19, but was found to be positive for COVID-19 and have viral traces in numerous parts of their body, including the respiratory system, the heart, the tissue in the eyes and the brain.
The cause of death ranged across the individuals. Thirty-eight died of COVID-19, while six died of another core issue while having COVID-19. Of those who were killed by the virus, 35 had either acute pneumonia or severe lung damage at their time of death.
Two of the patients included had only mild symptoms of COVID-19 and had died of other causes, but still were found to have SARS-CoV-2 RNA spread widely throughout their bodies, suggesting that although the bulk of the autopsies focused on severe and fatal cases, the virus can penetrate far into the body even in mild cases.
The study is limited by its small scope and its focus on unvaccinated, older individuals who died with COVID-19, meaning these results may not reflect what occurs when younger, vaccinated individuals contract the virus.
Previous autopsy research has found evidence of COVID-19 across multiple systems, but some have theorized that viral traces found outside the respiratory system could’ve been due to residual blood left in tissues or cross-contamination. Researchers say that is not the case in this new study, which confirmed SARS-CoV-2 at the cellular level.
How long the virus persisted within the tissue was another aspect researchers were interested in. They found that among those who had a longer interval between symptom onset and death, the difference between the level of virus in the respiratory and non-respiratory tissues diminished significantly. This may be because different tissues are better at fighting the virus and identifying it, researchers theorized.
“Understanding mechanisms by which SARS-CoV-2 evades immune detection is essential to guide future therapeutic approaches to facilitate viral clearance,” the authors stated.
News
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
Self-Organizing Light Could Transform Computing and Communications
USC engineers have demonstrated a new kind of optical device that lets light organize its own route using the principles of thermodynamics. Instead of relying on switches or digital control, the light finds its own [...]
Groundbreaking New Way of Measuring Blood Pressure Could Save Thousands of Lives
A new method that improves the accuracy of interpreting blood pressure measurements taken at the ankle could be vital for individuals who are unable to have their blood pressure measured on the arm. A newly developed [...]
Scientist tackles key roadblock for AI in drug discovery
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages is important for reducing cost and accelerating the path [...]
